427 Results (Page 1 of 18)
Egypt Markets Research Reports
Egypt Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Analysis
Egypt's Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics market is expected to grow from $10 Mn in 2022 to $25 Mn in 2030 with a CAGR of 11.70% for the year 2022-30. The introduction of new treatment alternatives in the Egyptian market may result from pharmaceutical companies' investments in the research and development of novel PNH therapies. The market is segmented by therapy, diagnostic tests, by distribution channels. Some key players in this market include Amoun Pharmaceutical, EIPICO, Minapharm Pharmaceuticals, Pharco Pharmaceuticals, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Akari Therapeutics, Amgen, CSL Behring, and Bioverativ.
Egypt Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Analysis
Egypt's Paroxysmal Nocturnal Hemoglobinuria (PNH) therapeutics market is expected to grow from $10 Mn in 2022 to $25 Mn in 2030 with a CAGR of 11.70% for the year 2022-30. The introduction of new treatment alternatives in the Egypt market may result from pharmaceutical companies' investments in the research and development of novel PNH therapies. The market is segmented by therapy, diagnostic test, and distribution channels. Some key players in this market include Amoun Pharmaceutical, EIPICO, Minapharm Pharmaceuticals, Pharco Pharmaceuticals, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Akari Therapeutics, Amgen, CSL Behring, and Bioverativ.
Egypt Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
Egypt's Chronic Obstructive Pulmonary Disease (COPD) therapeutics market was valued at $51 Mn in 2022 and is estimated to expand at a CAGR of 8.6% from 2022 to 2030 and will reach $99 Mn in 2030. One of the main reasons propelling the growth of this market is government initiatives, Aging population. The market is segmented by Drug class and By distribution channel. Some key players in this market are EIPICO, Pharco, Amoun, Memphis Pharmaceutical, Eva Pharma, Almirall, Astellas Pharma, American Hospital of Paris, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, and others.
Egypt Dental Care Market Analysis
Egypt's dental care market size was valued at $ 100 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030 and will reach $185 Mn in 2030. A significant factor influencing demand for oral care products is the increased incidence of dental caries. The market is segmented by product, age group, and sales channels. The major players in the market are Procter & Gamble Company Johnson & Johnson Services, Inc., Colgate-Palmolive Company, and others.
Egypt Central Nervous System (CNS) Therapeutics Market Analysis
The Egypt Central Nervous System (CNS)Therapeutics Market was valued at $588 Mn in 2022 and is predicted to grow at a CAGR of 7.9% from 2023 to 2030, to $1,080 Mn by 2030. The key drivers of this industry include the upward surge in the prevalence of CNS disorders, high unmet medical needs, and the growing pharmaceutical industry. The industry is primarily dominated by players such as Hikma, Novartis, EIPICO, AstraZeneca, Pharco, Eva, Pfizer, and Roche among others.
Egypt Cholesterol Therapeutics Market Analysis
The Egypt Cholesterol Therapeutics Market is anticipated to experience a growth from $68 Mn in 2022 to $94 Mn by 2030, with a CAGR of 4.1 % during the forecast period of 2022-2030. The market is being driven by the confluence of innovative drug classes in the treatment of cholesterol-induced diseases, the escalating prevalence of cardiovascular diseases, and the collaborative efforts between public and private entities. The Egypt Cholesterol Therapeutics Market encompasses various players across different segments such as Pfizer, Sanofi, Bayer, AstraZeneca, Novartis, MinaPharm, Nile Pharma, EIPICO, Pharco Pharmaceuticals, EVA Pharma, etc., among various others.
Egypt Nutritional Supplements Market Analysis
By 2030, it is anticipated that the Egypt Nutrition and Supplements market will reach a value of $2.29 Bn from $1.07 Bn in 2022, growing at a CAGR of 10% during 2022-2030. The nutritional supplements market in Egypt is primarily dominated by local players such as Amoun Pharmaceutical, Pharmed Healthcare, and EVA Pharma. The market for nutrition and supplements in the Egypt is primarily driven by an inclination towards better health infrastructure, government regulations and increasing consumer awareness of health and lifestyle. The Egypt nutrition and supplements market in Egypt is segmented by Type, Product, application, and Distribution Channel.
Egypt Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis
This report presents a strategic analysis of the Egypt Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy, and expert insights.
Egypt Alzheimer’s Therapeutics Market Analysis
Egypt alzheimer’s therapeutics market valued at $13 Mn in 2022, projected to reach $30 Mn by 2030 with a 10.6% CAGR. The growing prevalence of Alzheimer's disease, which is fuelled by an aging population, is the main factor driving the market for drugs used to treat the condition. The leading pharmaceutical companies presently working in the industry are Eisai, Biogen, GlaxoSmithKline, Novartis, Pfizer, Roche, Johnson & Johnson, Eli Lilly, AstraZeneca and Merck & Co.
Egypt Infectious Disease Drugs Market Analysis
Egypt Infectious Disease Drugs Market valued at $0.33 Bn in 2023, projected to reach $0.49 Bn by 2030 with a 5.77% CAGR. The market is expanding due to factors like aging populations, rising levels of awareness and education, and emerging infectious diseases. The market is dominated by key players like EIPICO, Pharco Pharmaceuticals, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
Egypt Atopic Dermatitis Therapeutics Market Analysis
The Egypt Atopic Dermatitis Therapeutics Market was valued at US $34 Mn in 2022, and is predicted to grow at (CAGR) of 10.3% from 2023 to 2030, to US $75 Mn by 2030. The key drivers of this industry include the increased burden of Atopic Dermatitis (AD), improving healthcare infrastructure, adverse environmental conditions, and others. The industry is primarily dominated by players such as Sanofi, Pfizer, AstraZeneca, Abbott, Novartis, and Johnson & Johnson, among others.
Egypt Atherosclerosis Therapeutics Market Analysis
Egypt Atherosclerosis Therapeutics Market was valued at $8 Mn in 2022 and is estimated to reach $14 Mn in 2030, exhibiting a CAGR of 7.2% during the forecast period. The rising prevalence of cardiovascular diseases, exacerbated by unhealthy dietary patterns, sedentary lifestyles, and a growing aging population worldwide, is anticipated to increase the need for atherosclerosis therapeutics. Leading pharmaceutical companies currently operating in the industry are Pfizer, Novartis, AstraZeneca, Sanofi, Bayer, Abbott, Eli Lilly, GlaxoSmithKline, Teva Pharmaceutical, and Roche.
Egypt HIV Drugs Market Analysis
Egypt HIV Drugs Market is at around $88.76 Mn in 2023 and is projected to reach $125.73 Mn in 2030, exhibiting a CAGR of 5.1% during the forecast period. The market is growing due to increased awareness, government initiatives, and international collaborations & funding. The market is dominated by key players like EVA Pharma, Gilead Sciences, ViiV Healthcare, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Merck & Co., Bristol-Myers Squibb, AbbVie Inc., F. Hoffmann-La Roche Ltd., and Novartis.
Egypt Antifungal Drugs Market Analysis
Egypt Antifungal Drugs Market is at around $0.04 Bn in 2023 and is projected to reach $0.06 Bn in 2030, exhibiting a CAGR of 5.3% during the forecast period. The market is driven by rising rates of fungal infections, the growth of the pharmaceutical industry, and government initiatives and policies. The market is dominated by key players like GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Novartis AG, Abbott Laboratories, Astellas Pharma Inc., Sanofi S.A., Bayer AG, Glenmark Pharmaceuticals Limited, and Gilead Sciences Inc.
Egypt Outpatient Rehabilitation Centers Market Analysis
Egypt outpatient rehabilitation centers market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. A few of the key aspects that are projected to drive growth in the global market are the rise in drug addiction instances, the prevalence of chronic diseases, advances in patient care, and rising demand for rehabilitation therapies. Some of the major key players in this market are AIM Health Group Inc., Accelerated Rehabilitation Centers, Ltd, Select Medical Holdings, etc.
Egypt Ovarian Cancer Drugs Market Analysis
Egypt ovarian cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is anticipated to develop as a result of the rising number of elderly women, rise in ovarian cancer cases, ease of use of new treatments and therapies, and increase in healthcare spending. Government spending is also accelerating the market's expansion. Some of the major key players in this market are F. Hoffmann-La Roche AG, Amgen Inc., Pfizer, Inc., Clovis Oncology, AstraZeneca, Abbvie Inc., etc.
Egypt Pancreatic Cancer Drugs Market Analysis
Egypt pancreatic cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Genetic anomalies including the BRCA2 gene mutation, Lynch syndrome, and familial atypical mole-malignant melanoma (FAMMM) syndrome may increase the risk of cancer running in the family. The dynamics of the market will be impacted by the rising rates of diabetes and obesity, which will raise the risk of pancreatic cancer. Some of the major key players in this market are Eli Lilly and Company, Celgene, Roche, Novartis, Clovis Oncology, etc.
Egypt Paracetamol Market Analysis
Egypt paracetamol market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising geriatric populations, expanding emerging markets, expanding R&D efforts in the healthcare industry, and rising technological developments and modernization in the paracetamol production process will all further open up new potential for the paracetamol market. Some of the key players in this market are Bristol Laboratories, GlaxoSmithKline, Mallinckrodt, Venipharm, Novacyl, FarmalíderGroup, bene-Arzneimittel GmbH, Wockhardt UK Ltd.
Egypt Parkinson Disease Market Analysis
Egypt parkinson disease market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key business drivers are anticipated to include the high prevalence of Parkinson's disease (PD) in western countries, the aging global population, which is at a high risk of contracting the disease, and the strong pipeline of drugs that treat the condition. Some of the major key players in this market are Sunovion Pharmaceuticals, Adamas Pharmaceuticals, Neurocrine Biosciences, Supernus Pharmaceuticals, etc.
Egypt Pediatric Healthcare Market Analysis
Egypt pediatric healthcare market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growth in the number of kids who need special care, greater knowledge of home healthcare, technological advancements, and rising disposable money are the market's main drivers. The life expectancy of newborns has increased as a result of improvements in medical intervention techniques. Some of the major key players in this market are Abbott, AstraZeneca, GlaxoSmithKline, Merck & Co., etc.
Egypt Pegfilgrastim- Biosimilar Market Analysis
Egypt Pegfilgrastim- Biosimilar market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pegfilgrastim- Biosimilar is growing rapidly as a result of rising demand for biosimilars because they are cost effective, increasing demand for oncology supportive care due to rising cases of oncology and chronic diseases globally including HIV/AIDS, expiration of patents of key innovator drugs, support from regulatory body’s like pathways for the approval of biosimilars, strong investments in healthcare infrastructure and in research and development. Merck & Co., Inc., Zydus Lifesciences Limited, Ratiopharm GmbH, Jiangsu Hengrui Pharmaceuticals Co. Ltd, Biocon Limited, Dr. Reddy's Laboratories Ltd, Pfizer Inc., Emcure Pharmaceuticals Limited, USV Private Limited, and Apotex Pty Ltd. are important market participants for pegfilgrastim biosimilars.
Egypt PEGylated Proteins Market Analysis
Egypt PEGylated Proteins market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for PEGylated Proteins is growing rapidly as a result of the growing incidence and prevalence of degenerative & chronic diseases like cancer, kidney diseases, and rheumatoid arthritis. Thermo Fisher Scientific Inc., Merck KGaA, NOF Corporation, Jenkem Technology, etc., are some of the key players in this market.
Egypt Peptic Ulcer Drugs Market Analysis
Egypt Peptic ulcer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for peptic ulcer drugs is growing rapidly as a result of the rising incidence and prevalence of peptic ulcer disease due to increasing alcohol and tobacco consumption, increasing stress levels, and the prevalence of Helicobacter pylori (a common bacteria associated with peptic ulcers), increasing investment in healthcare infrastructure, increasing adoption of over the counter drugs, increase in research and development activities and a strong pipeline for new drugs also contribute to the market growth. Allergan, AstraZeneca, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, etc. are some of the key this market.
Egypt Peptide and Anticoagulant Drugs Market Analysis
Egypt Peptide and Anticoagulant Drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Peptide and Anticoagulant Drugs is growing rapidly as a result of an increase in the incidence and prevalence of cardiovascular disorders like coronary heart disease and myocardial infarction (MI), wide therapeutic applications of peptide and anticoagulants drugs, increasing research and development activities and advancements in peptide synthesis technologies. Baxter, Hemmo, PharmaBiofer, Wockhardt, AmbioPharm, Bachem, etc. are some the key market players operating globally.
Egypt pH Meters Market Analysis
Egypt PH Meters market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for pH Meters is growing rapidly as a result of growing awareness about environmental monitoring, wide applications of pH meters, technological advancements in PH meter technology, and availability of pH meters in different types including portable handheld meters, benchtop meters, and continuous online monitoring systems. Halma PLC, Thermo Fisher Scientific Inc., Xylem Inc., Yokogawa Electric Corporation, and George Fischer Piping Systems Ltd. are the key global market players in the this market.